Are We Ready to Bell The Cat? A Call for Cardiologists to Embrace Glucose-Lowering Therapies Proven to Improve Cardiovascular Outcomes

Circulation. 2018 Jul 3;138(1):4-6. doi: 10.1161/CIRCULATIONAHA.117.022680.

Authors

Michael E Nassif¹, Mikhail Kosiborod^{2

3}

Affiliations

¹ Saint Luke's Mid America Heart Institute, Kansas City, MO (M.E.N., M.K.).
² Saint Luke's Mid America Heart Institute, Kansas City, MO (M.E.N., M.K.) mkosiborod@saint-lukes.org.
³ University of Missouri-Kansas City, MO (M.K.).

PMID: 29967227
DOI: 10.1161/CIRCULATIONAHA.117.022680

No abstract available

Keywords: diabetes mellitus, type 2; sodium-glucose transporter 2; treatment outcome.

MeSH terms

Attitude of Health Personnel*
Biomarkers / blood
Blood Glucose / drug effects*
Blood Glucose / metabolism
Cardiologists / psychology*
Cardiovascular Diseases / diagnosis
Cardiovascular Diseases / drug therapy*
Cardiovascular Diseases / mortality
Diabetes Mellitus, Type 2 / blood
Diabetes Mellitus, Type 2 / diagnosis
Diabetes Mellitus, Type 2 / drug therapy*
Diabetes Mellitus, Type 2 / mortality
Evidence-Based Medicine
Health Knowledge, Attitudes, Practice*
Humans
Incretins / therapeutic use*
Risk Factors
Sodium-Glucose Transporter 2 Inhibitors / therapeutic use*
Treatment Outcome

Substances

Biomarkers
Blood Glucose
Incretins
Sodium-Glucose Transporter 2 Inhibitors